Li Q, de Oliveira Formiga R, Puchois V, Creusot L, Ahmad AH, Amouyal S, Campos-Ribeiro MA, Zhao Y, Harris DMM, Lasserre F, Ellero-Simatos S, Guillou H, Huang Z, Brot L, Hu Y, Chollet L, Danne C, Scandola C, Ledent T, Chevreux G, Argüello RJ, De Carvalho Bittencourt M, Bettinger J, D'Aveni-Piney M, Moulin D, Schreiber S, Aden K, Rolhion N, Michel ML, Wai T, Sokol H

Nat Metab. 2025 10 21;:

Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availability.

Sebert M, Thepot S, Cluzeau T, Duployez N, Lefebvre T, Chaffaut C, Orvain C, Loschi M, Peterlin P, Chevallier P, D'Aveni M, Rubio MT, Rauzy O, Huynh A, Charbonnier A, Sapena R, Chermat F, Ceballos P, Fossard G, Nguyen S, Park S, Adès L, Peffault De Latour R, Preudhomme C, Fenaux P, Chevret S, Robin M

Blood Adv. 2025 10 8;:

[Imetelstat for low and intermediate risk myelodysplastic syndromes without 5q deletion in transfusion-dependant patients].

Malbrun C, D'Aveni M

Bull Cancer. 2025 09 17;:

Optimized GMP-grade Wharton's jelly's mesenchymal stromal cells manufacturing and administration protocol for Graft versus Host disease prevention.

Pochon C, Perouf R, Notarantonio AB, Bertrand A, Charif N, Marcelo CB, Fouquet G, Cauchois G, Bensoussan D, Moulin D, Pagliuca S, de Isla N, Sartelet H, D'Aveni M, Rubio MT

Curr Res Transl Med. 2025 09 10;73(4):103543

Allogeneic hematopoietic stem cell transplantation in germline DDX41 mutated patients with myeloid malignancies.

Loschi M, Villy MC, Galimard JE, Auboiroux MM, Gachard N, Perani A, Duchmann M, Largeaud L, Nguyen S, Sicre de Fontbrune F, Robin M, Yakoub-Agha I, Daguindau E, Chantepie SP, Charbonnier A, Lebon D, Maury S, Labussiere-Wallet H, Huynh A, Forcade E, Castilla-Llorente C, Cluzeau T, Adès L, D'Aveni M, Devillier R, Maillard N, Benachour S, Dombret H, Récher C, Pigneux A, Clappier E, Delabesse E, Duployez N, Turlure P, Peffault De Latour R, Sebert M

Blood Adv. 2025 09 9;:

Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial.

Robin M, D'Aveni M, Stamatoullas A, Raffoux E, Chevallier P, Garnier A, Mediavilla C, Carre M, Himberlin C, Sébert M, Ravinet A, Desseaux K, Labussière H, Alani M, Rubio MT, Huynh A, Adès L, de Latour RP, Paul F, Chermat F, Petit R, Mokeddem C, Charbonnier A, Thépot S, Chevret S, Fenaux P,

Lancet Haematol. 2025 08 7;:

Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM.

D'Aveni M, Schenone L, Torregrosa JM, Pardo J, Stamatoullas A, Saillard C, Thépot S, Dimicoli S, Santana C, Daguindau E, Paul F, Le Clech L, Park S, Cluzeau T, Paubelle E, Taksin-Bressot AL, Chermat F, Adès L, Fenaux P, Comont T

Br J Haematol. 2025 07 2;:

Incidence and Burden of Lower-Risk Myelodysplastic Syndrome: A Nationwide Population Study.

D'Aveni M, Fernandes J, Chartier M, Cotté FE, Pagès N, Panes A, Schmidt A, Webert L, Comont T

Clin Lymphoma Myeloma Leuk. 2025 06 18;:

Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy.

Michonneau D, Malard F, Le Grand S, Magro L, D'Aveni M, Tudesq JJ, Villate A, Meunier M, Maillard N, Castilla-Llorente C, Marçais A, Cabrera Q, Huynh A, Menard AL, Forcade E, Labussière-Wallet H, Raus N, Loschi M

Bone Marrow Transplant. 2025 04 1;:

Differential Clinical and Immunological Impacts of Anti-T-Lymphocyte Globulin (ATLG) vs. Anti-Thymocyte Globulin (ATG) in Preventing Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comparative Study.

Notarantonio AB, Morisset S, Piucco R, Pérès M, Boulangé L, Alitcher A, Brouard J, Monchablon L, Campidelli A, El Ouahabi S, Guisnel C, Moulin C, Kicki C, Roth-Guepin G, Feugier P, Bittencourt MC, Aarnink A, D'Aveni-Piney M, Hergalant S, Pagliuca S, Rubio MT

Am J Hematol. 2025 02 4;:

Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study.

Garelius HKG, Bagguley T, Taylor A, Fenaux P, Bowen D, Symeonidis A, Mittelmann M, Stauder R, Čermák J, Sanz G, Langemeijer S, Malcovati L, Germing U, Sanhes L, d'Aveni M, Culligan D, Kotsianidis I, Koinig KA, van Marrewijk C, Crouch S, deWitte T, Smith A, Hellström-Lindberg E

Lancet Haematol. 2025 02;12(2):e128-e137

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

Rombaut D, Sandmann S, Tekath T, Crouch S, de Graaf AO, Smith A, Painter D, Kosmider O, Tobiasson M, Lennartsson A, van der Reijden BA, Park S, D'Aveni M, Slama B, Clappier E, Fenaux P, Adès L, van de Loosdrecht A, Langemeijer S, Symeonidis A, Čermák J, Preudhomme C, Savic A, Germing U, Stauder R, Bowen D, van Marrewijk C, Bernard E, de Witte T, Varghese J, Hellström-Lindberg E, Dugas M, Martens J, Malcovati L, Jansen JH, Fontenay M,

Hemasphere. 2025 01;9(1):e70073

Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study.

Rabian F, Chevret S, Gruson B, Thépot S, Walter-Petrich A, Braun T, Vey N, Torregrosa-Diaz JM, Peterlin P, Toma A, D'Aveni M, Delaunay J, Legros L, Droin N, Chermat F, Lusina D, Adès L, Sapena R, Solary E, Fenaux P, Itzykson R

Leukemia. 2024 09 12;:

[Place of hematopoietic stem cell transplantation for very high risk acute myeloblastic leukemia and myelodysplastic syndromes (SFGM-TC)].

Mediavilla C, D'Aveni M, Huynh A, Joris M, Masouridi-Levrat S, Nguyen S, Turlure P, Magro L, Guillaume T

Bull Cancer. 2024 09 5;:

Current challenges in conditioning regimens for MDS transplantation.

Notarantonio AB, Robin M, D'Aveni M

Blood Rev. 2024 07 10;:101223

Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation.

Notarantonio AB, Bertrand A, Piucco R, Fievet G, Sartelet H, Boulangé L, de Isla N, De Carvalho Bittencourt M, Hergalant S, Rubio MT, D'Aveni M

Exp Hematol Oncol. 2024 05 11;13(1):50

Efficacy of eculizumab in transplantation-associated thrombotic microangiopathy: results of the French nationwide study on behalf of the SFGM-TC and the CNR-MAT.

Peyre M, Sicre de Fontbrune F, Berceanu A, Benjemia L, Castelle M, D'Aveni M, Marçais A, Kaphan E, Bulabois CE, Sirvent A, Rohrlich PS, Coiteux V, Chantepie S, Nguyen-Quoc S, Peffault de Latour R, Coppo P

Bone Marrow Transplant. 2024 04 11;:

On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.

Leroyer EH, Petitpain N, Morisset S, Neven B, Castelle M, Winter S, Souchet L, Morel V, Le Cann M, Fahd M, Yacouben K, Mechinaud F, Ouachée-Chardin M, Renard C, Wallet HL, Angoso M, Jubert C, Chevallier P, Léger A, Rialland F, Dhedin N, Robin C, Maury S, Beckerich F, Beauvais D, Cluzeau T, Loschi M, Fernster A, Bittencourt MC, Cravat M, Bilger K, Clément L, Decot V, Gauthier M, Legendre A, Larghero J, Ouedrani A, Martin-Blondel G, Pochon C, Reppel L, Rouard H, Nguyen-Quoc S, Dalle JH, D'Aveni M, Bensoussan D

Hemasphere. 2024 01;8(1):e40

Comparison of two reduced intensity conditioning regimens: Flu-Bu2 versus RIC-TBF in allogeneic hematopoietic stem cell transplantation.

Verstraete E, Baumann C, Rousseau H, Campidelli A, Rubio MT, D'Aveni M

Leuk Lymphoma. 2023 11 21;:1-4

A new sequential conditioning regimen based on CPX- 351/Vyxeos ("Vyx-Seq") in patients with higher risk myelodysplastic syndromes.

Notarantonio AB, Roth-Guépin G, Bonmati C, Divoux M, Kicki C, Pagliuca S, Campidelli A, Rubio MT, D'Aveni-Piney M

Leuk Res. 2023 10 16;135:107405

Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial.

Notarantonio AB, D'aveni-Piney M, Pagliuca S, Ashraf Y, Galimard JE, Xhaard A, Marçais A, Suarez F, Brissot E, Feugier P, Urien S, Bouazza N, Jacquelin S, Meatchi T, Bruneval P, Frémeaux-Bacchi V, Peffault De Latour R, Hermine O, Durey-Dragon MA, Rubio MT

Am J Hematol. 2023 07 22;:

Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.

Maccari ME, Wolkewitz M, Schwab C, Lorenzini T, Leiding JW, Aladjdi N, Abolhassani H, Abou-Chahla W, Aiuti A, Azarnoush S, Baris S, Barlogis V, Barzaghi F, Baumann U, Bloomfield M, Bohynikova N, Bodet D, Boutboul D, Bucciol G, Buckland MS, Burns SO, Cancrini C, Cathébras P, Cavazzana M, Cheminant M, Chinello M, Ciznar P, Coulter TI, D'Aveni M, Ekwall O, Eric Z, Eren E, Fasth A, Frange P, Fournier B, Garcia-Prat M, Gardembas M, Geier C, Ghosh S, Goda V, Hammarstrom L, Hauck F, Heeg M, Heropolitanska-Pliszka E, Hilfanova A, Jolles S, Karakoc-Aydiner E, Kindle GR, Klemann C, Koletsi P, Koltan S, Kondratenko I, Körholz J, Krüger R, Jeziorski E, Levy R, Le Guenno G, Lefevre G, Lougaris V, Marzollo A, Mahlaoui N, Malphettes M, Meinhardt A, Merlin E, Meyts I, Milota T, Moreira F, Moshous D, Mukhina A, Neth O, Neubert J, Neven B, Nieters A, Nove-Josserand R, Oksenhendler E, Ozen A, Olbrich P, Perlat A, Pac M, Schmid JP, Pacillo L, Parra-Martinez A, Paschenko O, Pellier I, Sefer AP, Plebani A, Plantaz D, Prader S, Raffray L, Ritterbusch H, Riviere JG, Rivalta B, Rusch S, Sakovich I, Savic S, Scheible R, Schleinitz N, Schuetz C, Schulz A, Sediva A, Semeraro M, Sharapova SO, Shcherbina A, Slatter MA, Sogkas G, Soler-Palacin P, Speckmann C, Stephan JL, Suarez F, Tommasini A, Trück J, Uhlmann A, van Aerde KJ, van Montfrans J, von Bernuth H, Warnatz K, Williams T, Worth AJ, Ip W, Picard C, Catherinot E, Nademi Z, Grimbacher B, Forbes Satter LR, Kracker S, Chandra A, Condliffe AM, Ehl S,

J Allergy Clin Immunol. 2023 06 28;:

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation.

Pagliuca S, Gurnari C, Hercus C, Hergalant S, Hong S, Dhuyser A, D'Aveni M, Aarnink A, Rubio MT, Feugier P, Ferraro F, Carraway HE, Sobecks R, Hamilton BK, Majhail NS, Visconte V, Maciejewski JP

Nat Commun. 2023 05 31;14(1):3153

Age-related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation.

Jandin A, Pochon C, Campidelli A, D'Aveni M, Kicki C, Notarantonio AB, Roth Guepin G, Mbuyi TA, Feugier P, Chastagner P, Schweitzer C, de Carvalho Bittencourt M, Rubio MT, Pagliuca S

Br J Haematol. 2023 04 24;:

A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.

Laroye C, Thilly N, Gauthier M, Luc A, Latger-Cannard V, Eschwege V, Bensoussan D, Pochon C, Campidelli A, Rubio MT, D'Aveni M, Decot V

Cytotherapy. 2023 04 17;:

Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.

Sutra Del Galy A, Willems L, D'Aveni M, Pautas C, Chantepie S, Carpentier B, Barraco F, Banos A, Garidi R, Forcade E, Sicre de Fontbrune F, Peffault de Latour R

Br J Haematol. 2023 02 17;:

A Serious Game About Hematology for Health Care Workers (SUPER HEMO): Development and Validation Study.

Perrin J, Meeus A, Broseus J, Morieux PJ, Di Ceglie V, Gravoulet J, D'Aveni M

JMIR Serious Games. 2023 02 13;11:e40350

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS.

Michel C, Robin M, Morisset S, Blaise D, Maertens J, Chevalier P, Castilla-Llorente C, Forcade E, Ceballos P, Yakoug-Agha I, Poire X, Carre M, Bay JO, Beguin Y, Loschi M, Huynh A, Guillerm G, François S, Mear JB, Duléry R, Suarez F, Bilger K, Cornillon J, Chalandon Y, Maillard N, Labussière-Wallet H, Charbonnier A, Turlure P, Berceanu A, Chantepie S, Maury S, Bazarbachi A, Menard AL, Nguyen-Quoc S, Rubio MT, D'Aveni M

Bone Marrow Transplant. 2023 02 11;:

Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M.

Gurnari C, Gagelmann N, Badbaran A, Awada H, Dima D, Pagliuca S, D'Aveni-Piney M, Attardi E, Voso MT, Cerretti R, Wolschke C, Rubio MT, Maciejewski JP, Kröger N

Leukemia. 2023 01 28;:

On behalf of the SFGM-TC: prophylactic donor lymphocyte infusion in patients treated with allogeneic stem-cell transplantation for high-risk myelodysplastic syndrome and acute myeloid leukemia.

Guisnel C, Schirmer L, Morisset S, Robin M, Labussière-Wallet H, Duléry R, Ceballos P, Forcade E, Nguyen S, Poiré X, Maertens J, Chantepie S, Chevallier P, Daguindau E, Villate A, Charbonnier A, Castilla-Llorente C, Contentin N, Huynh A, Yakoub-Agha I, Bulabois CE, Rubio MT, D'Aveni M

Acta Haematol. 2023 01 5;:

Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC.

Jondreville L, D'Aveni M, Labussière-Wallet H, Le Bourgeois A, Villate A, Berceanu A, Bezsera SM, Thiebaut A, Boissard-Simonet M, Legrand M, Cornillon J, Rubio MT, Chevallier P, Nguyen S

J Hematol Oncol. 2022 11 28;15(1):169

A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML.

Mekinian A, Zhao LP, Chevret S, Desseaux K, Pascal L, Comont T, Maria A, Peterlin P, Terriou L, D'Aveni Piney M, Gourin MP, Vey N, Rauzy OB, Grobost V, Bezanahary H, Dimicoli-Salazar S, Banos A, Wickenhauser S, De Renzis B, Durot E, Natarajan-Amé S, Voillat L, Chermat F, Lemaire K, Jachiet V, Himberlin C, Thépot S, Diaz JMT, Frenzel L, Gyan E, Denis G, Hirsch P, Kosmider O, Ades L, Fain O, Fenaux P

Leukemia. 2022 09 14;:

Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases.

Jachiet V, Ricard L, Hirsch P, Malard F, Pascal L, Beyne-Rauzy O, Peterlin P, Maria ATJ, Vey N, D'Aveni M, Gourin MP, Dimicoli-Salazar S, Banos A, Wickenhauser S, Terriou L, De Renzis B, Durot E, Natarajan-Ame S, Vekhoff A, Voillat L, Park S, Vinit J, Dieval C, Dellal A, Grobost V, Willems L, Rossignol J, Solary E, Kosmider O, Dulphy N, Zhao LP, Adès L, Fenaux P, Fain O, Mohty M, Gaugler B, Mekinian A,

Clin Exp Med. 2022 08 11;:

Neuropilin-1 cooperates with PD-1 in CD8 T cells predicting outcomes in melanoma patients treated with anti-PD1.

Rossignol J, Belaid Z, Fouquet G, Guillem F, Rignault R, Milpied P, Renand A, Coman T, D'Aveni M, Dussiot M, Colin E, Levy J, Carvalho C, Goudin N, Cagnard N, Côté F, Babdor J, Bhukhai K, Polivka L, Bigorgne AE, Halse H, Marabelle A, Mouraud S, Lepelletier Y, Maciel TT, Rubio MT, Heron D, Robert C, Girault I, Lebeherec D, Scoazec JY, Moura I, Condon L, Weimershaus M, Pages F, Davoust J, Gross D, Hermine O

iScience. 2022 06 17;25(6):104353

Allogeneic stem cell transplantation-A curative treatment for paroxysmal nocturnal hemoglobinuria with PIGT mutation: A case report.

Schenone L, Notarantonio AB, Latger-Cannard V, Fremeaux-Bacchi V, De Carvalho-Bittencourt M, Rubio MT, Muller M, D'Aveni M

World J Clin Cases. 2022 06 16;10(17):5702-5707

Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation.

Pochon C, Notarantonio AB, Laroye C, Reppel L, Bensoussan D, Bertrand A, Rubio MT, D'Aveni M

J Cell Mol Med. 2022 Jan 28;:

Antibody Response after 2 and 3 doses of SARS-CoV-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients.

Maillard A, Redjoul R, Klemencie M, Labussiere-Wallet H, Le Bourgeois A, D'Aveni M, Huynh A, Berceanu A, Marchand T, Chantepie SP, Botella-Garcia C, Loschi M, Joris M, Castilla-Llorente C, Thiebaut-Bertand A, Francois SS, Leclerc M, Chevallier P, Nguyen S

Blood. 2021 Nov 24;:

On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.

Campidelli A, Robin M, Remen T, Luc A, Labussière-Wallet H, Dulery R, Srour M, Ceballos P, Forcade E, Nguyen-Quoc S, Furst S, Turlure P, Bay JO, Simand C, Marçais A, Daguindau E, Rubio MT, D'Aveni M

Clin Lymphoma Myeloma Leuk. 2021 Jul 31;:

Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study.

Xhaard A, Xhaard C, D'Aveni M, Salvator H, Chabi ML, Berceanu A, Coman T, Beguin Y, Chalandon Y, Poiré X, Loschi M, Paillard C, Bruno B, Ceballos P, Dalle JH, Bilger K, Bay JO, Robin M, N'Guyen-Quoc S, Rubio MT

Br J Haematol. 2021 Feb 1;:

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.

Vercellino L, Di Blasi R, Kanoun S, Tessoulin B, Rossi C, D'Aveni-Piney M, Obéric L, Bodet-Milin C, Bories P, Olivier P, Lafon I, Berriolo-Riedinger A, Galli E, Bernard S, Rubio MT, Bossard C, Meignin V, Merlet P, Feugier P, Le Gouill S, Ysebaert L, Casasnovas O, Meignan M, Chevret S, Thieblemont C

Blood Adv. 2020 Nov 24;4(22):5607-5615

Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study.

Roupie AL, Guedon A, Terrier B, Lahuna C, Jachiet V, Regent A, de Boysson H, Carrat F, Seguier J, Terriou L, Versini M, Queyrel V, Groh M, Benhamou Y, Maurier F, Ledoult E, Clech LL, D'Aveni M, Rossignol J, Galland J, Willems L, Chiche NJ, Peterlin P, Roux-Sauvat M, Parcelier A, Wemeau M, Lambert M, Belizna C, Puechal X, Swiader L, Cohen-Valensi R, Noc V, Dao E, Thepot S, de Frémont GM, Tanguy-Schmidt A, Koka AM, Bussone G, Philipponnet C, Konate A, Cavaille G, Guilpain P, Allain JS, Broner J, Solary E, Ruivard M, de Renzis B, Corm S, Baati N, Schleinitz N, Ponsoye M, Stamatoullas-Bastard A, Ades L, Dellal A, Tchirkov A, Aouba A, Fenaux P, Fain O, Mekinian A,

Semin. Arthritis Rheum.. 2020 Jul 11;50(5):879-884

Letermovir for secondary prophylaxis of CMV infection and disease after allogeneic hematopoietic cell transplantation: Results from the French compassionate program.

Robin C, Thiebaut A, Alain S, de Fontbrune FS, Berceanu A, D'Aveni M, Ceballos P, Redjoul R, Nguyen-Quoc S, Bénard N, Pahlavan-Grumel G, Cordonnier C

Biol. Blood Marrow Transplant.. 2020 Feb 5;:

Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease.

D'Aveni M, Notarantonio AB, Agbogan VA, Bertrand A, Fouquet G, Gastineau P, Garfa-Traoré M, De Carvalho M, Hermine O, Rubio MT, Zavala F

Front Immunol. 2020 ;11:607180

Mobilized Multipotent Hematopoietic Progenitors Stabilize and Expand Regulatory T Cells to Protect Against Autoimmune Encephalomyelitis.

Korniotis S, D'Aveni M, Hergalant S, Letscher H, Tejerina E, Gastineau P, Agbogan VA, Gras C, Fouquet G, Rossignol J, Chèvre JC, Cagnard N, Rubio MT, Hermine O, Zavala F

Front Immunol. 2020 ;11:607175

Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.

D'Aveni M, Notarantonio AB, Bertrand A, Boulangé L, Pochon C, Rubio MT

Front Immunol. 2020 ;11:989

Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review.

Roupie AL, de Boysson H, Thietart S, Carrat F, Seguier J, Terriou L, Versini M, Queyrel V, Groh M, Benhamou Y, Maurier F, Decaux O, d'Aveni M, Rossignol J, Galland J, Solary E, Willems L, Schleinitz N, Ades L, Dellal A, Samson M, Aouba A, Fenaux P, Fain O, Mekinian A,

Autoimmun Rev. 2019 Dec 12;:102446

Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.

Hadjadj J, Guffroy A, Delavaud C, Taieb G, Meyts I, Fresard A, Streichenberger N, L'Honneur AS, Rozenberg F, D'Aveni M, Aguilar C, Rosain J, Picard C, Mahlaoui N, Lecuit M, Hermine O, Lortholary O, Suarez F

J. Clin. Immunol.. 2018 Dec 14;:

Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report.

D'Aveni-Piney M, Divoux M, Busby-Venner H, Muller M, Broséus J, Feugier P

J Med Case Rep. 2018 Jun 12;12(1):164

Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study.

Campidelli A, Qian C, Laroye C, Decot V, Reppel L, D'aveni M, Bensoussan D

Cytotherapy. 2018 Apr;20(4):524-531

Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy,

Tozatto-Maio K, Giannotti F, Labopin M, Ruggeri A, Volt F, Paviglianiti A, Kenzey C, Hayashi H, Cornelissen J, Michallet M, Karakasis D, Deconinck E, Rohrlich PS, de la Tour RP, Blaise D, Petersen E, D'Aveni M, Sengeloev H, Lamy T, Russell NH, Forcade E, Craddock CF, Nagler A, Gluckman E, Rocha V

Biol. Blood Marrow Transplant.. 2018 Mar 1;:

Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT.

Qian C, Wang Y, Reppel L, D'aveni M, Campidelli A, Decot V, Bensoussan D

Bone Marrow Transplant.. 2018 Feb;53(2):114-122

Human CD4- invariant NKT lymphocytes regulate graft versus host disease.

Coman T, Rossignol J, D'Aveni M, Fabiani B, Dussiot M, Rignault R, Babdor J, Bouillé M, Herbelin A, Coté F, Moura IC, Hermine O, Rubio MT

Oncoimmunology. 2018 ;7(11):e1470735

Update on Actinomucor elegans, a mucormycete infrequently detected in human specimens: how combined microbiological tools contribute efficiently to a more accurate medical care.

Dorin J, D'Aveni M, Debourgogne A, Cuenin M, Guillaso M, Rivier A, Gallet P, Lecoanet G, Machouart M

Int. J. Med. Microbiol.. 2017 Dec;307(8):435-442

Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.

Qian C, Campidelli A, Wang Y, Cai H, Venard V, Jeulin H, Dalle JH, Pochon C, D'aveni M, Bruno B, Paillard C, Vigouroux S, Jubert C, Ceballos P, Marie-Cardine A, Galambrun C, Cholle C, Clerc Urmes I, Petitpain N, De Carvalho Bittencourt M, Decot V, Reppel L, Salmon A, Clement L, Bensoussan D

J Hematol Oncol. 2017 May;10(1):102

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working

Rubio MT, D'Aveni-Piney M, Labopin M, Hamladji RM, Sanz MA, Blaise D, Ozdogu H, Daguindeau E, Richard C, Santarone S, Irrera G, Yakoub-Agha I, Yeshurun M, Diez-Martin JL, Mohty M, Savani BN, Nagler A

J Hematol Oncol. 2017 01 24;10(1):31

An usual cause of elliptocytosis.

Broséus J, Roth-Guépin G, D'Aveni-Piney M, Perrot A, Lesesve JF, Perrin J

Ann. Biol. Clin. (Paris). 2016 Dec;74(6):704-707

Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.

Devillier R, Dalle JH, Kulasekararaj A, D'aveni M, Clément L, Chybicka A, Vigouroux S, Chevallier P, Koh M, Bertrand Y, Michallet M, Zecca M, Yakoub-Agha I, Cahn JY, Ljungman P, Bernard M, Loiseau P, Dubois V, Maury S, Socié G, Dufour C, Peffault de Latour R

Haematologica. 2016 07;101(7):884-90

Depletion of CD11c⁺ cells in the CD11c.DTR model drives expansion of unique CD64⁺ Ly6C⁺ monocytes that are poised to release TNF-α.

Sivakumaran S, Henderson S, Ward S, Sousa PS, Manzo T, Zhang L, Conlan T, Means TK, D'Aveni M, Hermine O, Rubio MT, Chakraverty R, Bennett CL

Eur. J. Immunol.. 2016 Jan;46(1):192-203

G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease.

D'Aveni M, Rossignol J, Coman T, Sivakumaran S, Henderson S, Manzo T, Santos e Sousa P, Bruneau J, Fouquet G, Zavala F, Alegria-Prévot O, Garfa-Traoré M, Suarez F, Trebeden-Nègre H, Mohty M, Bennett CL, Chakraverty R, Hermine O, Rubio MT

Sci Transl Med. 2015 Apr 1;7(281):281ra42

The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation.

D'Aveni M, Aissi-Rothe L, Venard V, Salmon A, Falenga A, Decot V, Virion JM, Wang Y, Clement L, Latger-Cannard V, Tomowiak C, Stoltz JF, Bordigoni P, Bensoussan D

Transpl Immunol. 2011 May;24(4):224-32

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques